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Background: Genetic studies have shown that variants in SPINK5 may be associated with atopic
diseases and asthma. However, the functional role of SPINK5 protein in asthma has not been
elucidated.
Objectives: To determine the effects of SPINK5 on asthma related physiological events such as
apoptosis, mucus and cytokine production by epithelial cells.
Methods: A549 cells were transfected with SPINK5 expression vector and stimulated with
increasing doses of hydrogen peroxide and neutrophil elastase (NE) for measurement of cell
viability or apoptosis and analysis of mucus production. Cell viability was measured by MTT
(3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyl-tetrazolium bromide) assay and apoptosis by An-
nexin V/PI staining. Levels of IL-4, IL-6, IL-8, IL-12, IL-13, IFNg, IL-1b and RANTES were deter-
mined by ELISA in cell culture supernatants. Mucus production was determined by RT-PCR of
the MUC5AC gene and PAS staining in NE treated cells.
Results: Epithelial cells transfected with SPINK5 expression vector produced more IL-6, IL-8
and RANTES compared to non-transfected cells (p < 0.001, p Z 0.003, p < 0.001, respec-
tively). Even though cells transfected with SPINK5 vector displayed significantly higher cell
death, we have not observed any clear effect of SPINK5 on apoptosis. PAS staining showed that
SPINK5 slightly decreased the mucin production induced by neutrophil elastase in A549 cells.
However, SPINK5 had no effect on MUC5AC transcription.
Conclusion: SPINK5 is an important molecule in asthma. Its role extends beyond its well known
protease inhibitor properties.
ª 2011 Elsevier Ltd. All rights reserved.3 727 6459; fax: þ90 312 441 9555.
e.edu.tr (O¨. Kalayci).
1 Elsevier Ltd. All rights reserved.
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The physiopathology of allergic diseases including asthma is
incompletely understood. It is generally believed that
asthma is the result of a complex network of various
genetic, immunological and environmental factors. Among
the many molecules that have been shown to play signifi-
cant roles in the pathogenesis of asthma, some have
emerged as dichotomous pairs, the net action of which may
determine the course of the pathological events. Within
this framework, in addition to some of the well known Th1/
Th2 molecules1 and oxidant/antioxidant forces,2 recent
studies have shown that the effects of stimulation by
proteases acting through membrane receptors and the
counteraction by anti-proteases may be important in the
pathogenesis of asthma.3,4
Proteases can be exogenous or endogenous. Well known
endogenous proteases include thrombin, plasmin, cathepsin
G and kallikrein. Central to the allergic inflammation, elas-
tase released by neutrophils and tryptase and chymase
released from mast cells have protease activity, as well.5 As
exogenous sources, almost all major allergens such as
pollens, fungi, mites, cockroaches and hymenoptera contain
proteases and various microorganisms such bacteria, rhino-
virus and influenza have protease activities.3,6e8
Proteases act through specific cell membrane receptors
calledProtease-ActivatedReceptors (PARs). These receptors
are expressed on almost all cell types and therefore prote-
ases have awide spectrumof action. In addition to their roles
in coagulation and homeostasis, they have the ability to
stimulate inflammatory cells and resident cells of the
airways, which make them critical for the inflammatory
diseases of the airways such as asthma. Various observations
have, in fact, supported this notion. In a mouse model of
asthma, lack of PAR2 signaling was shown to decrease the
eosinophilic infiltration and airway hyper-reactivity.9 Stim-
ulation of the airway epithelial by proteases was shown to
result in increased synthesis of interleukin (IL)-6, IL-8, GM-
CSF, eotaxin and platelet derived growth factor.10 Mast cell
tryptase increases the expression of PARs on epithelial cells
and disturbs tight junctions between cells and stimulates
collagen production by fibroblasts.11 Neutrophilic proteases
cathepsin G and elastase as well as mast cell chymase
increases the mucus production from epithelial cells and
mucus glands. Expression of adhesion molecules such as P
and E selectins, Inter-Cellular Adhesion Molecule 1 (ICAM-1)
and vascular cell adhesion molecule 1 (VCAM-1) increased in
endothelial cell stimulated with PAR agonists.12
The human body is equipped with a number of protease
inhibitors and activation of proteases counter-activates
protease inhibitors which balance the noxious effects of
proteases from endogenous and exogenous sources. The best
knownclinical example is alpha-1 anti-tyripsin andneutrophil
elastase. A genetic deficiency in the protease inhibitor alpha-
1 anti-tyripsin leads to unopposed action of the protease
leading to emphysema.13 In a mouse model of asthma it was
shown that removal of proteases from allergens results in
decreased airway responsiveness and inflammation.14
Furthermore, administration of a serine protease inhibitor
during sensitization to house dust mite was shown to prevent
the development of allergic inflammation and airway hyper-reactivity, and the production of IL-8 and GM-CSF produc-
tion by airway epithelial cells stimulatedwithmite extracts.3
One of the serine protease inhibitors, lymphoepithelial
Kazal type 5 (LEKTI) encoded by SPINK5 gene on chromosome
5q31-32 within the cytokine cluster region, was shown to be
related with asthma in several studies. SPINK5 contains 33
exons and encodes a precursor protein of 1064 amino acids.15
SPINK5 plays critical role in the epidermal barrier function by
regulating protease activity.16 Dysfunction of this gene leads
to atopic manifestations in skin due to unbalanced protease
activity. In addition, mutations in this gene have been found
to be related to Netherton syndrome characterized by
abnormal desquamation of skin, elevated IgE levels, and
atopic manifestations.16
Because of its biological properties and the localization
of the gene, a number of studies have focused on searching
for associations between the genetic variants of the SPINK5
gene and atopy, atopic dermatitis and asthma.17e19 Even
though many studies have investigated the role of genetic
variants that belong to the SPINK5 gene, the functional role
of SPINK5 protein in asthma is not well elucidated. We
hypothesized that, similar to various proteases and
protease inhibitors, participation of SPINK5 protein in
asthma extend beyond its protease inhibition properties
and we aimed to determine the physiological role of SPINK5
on asthma related physiological events such as apoptosis,
mucus and cytokine production by epithelial cells.
Materials and methods
Cell culture and cytokine measurements
A549 cells (DSMZ, Braunschweig, Germany) were grown in
1640 RPMI (GIBCO BRL, Grand Island, NY) supplemented
with 10% Fetal bovine serum (GIBCO BRL, Grand Island, NY),
100 U/ml penicillin and 100 mg/ml streptomycin in 5% CO2
atmosphere at 37 C. A549 cells were seeded in 24 well
culture dishes and 24 h later cells were transiently trans-
fected with SPINK5 full length expression vector (a kind gift
by Dr. Marina D’alessio, Instituto Dermopatico Dell’imma-
colata, Roma, Italy) using lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA, USA) in accordance with the
manufacturer’s instructions. In order to determine the
effect of SPINK5 on protease induced cytokine production
by epithelium, transfected and untransfected cells were
stimulated with Der p1 at 1 mg, an antigen with known
protease activity. 48 h after transfection, supernatants
were collected and stored at 80 C until analysis. Effi-
ciency of transfection with SPINK5 expression vector was
checked by a PCR based method. RNA was extracted from
mock transfected and SPINK5 transfected cells. SPINK5
gene was amplified by primer pairs designed according to
the RNA sequence of the gene. Transfection efficiency was
proven before proceeding to each set of experiments.
We have chosen representatives from a wide spectrum of
cytokines and chemokines that may have a strong effect on
the eosinophilic airway inflammation that is a characteristic
of asthma and determined the concentrations of IL-1b, INF-
g, IL-4, IL-6, IL-8, IL-12, IL-13 and RANTES (regulated upon
activation, normal T cell expressed and secreted) using
commercial enzyme-linked immunosorbent assay (ELISA)
Figure 1 Control of transfection efficacy by RT-PCR
(A Z Non-transfected A549 cells, B Z Cells transfected with
SPINK5 expression vector (unstimulated), C Z Cells trans-
fected with SPINK5 expression vector and stimulated with NE
(200 mM) D Z SPINK5 vector DNA as a positive control of PCR
reaction).
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USA) according to the manufacturer’s instructions.
Measurement of cell viability
A549 epithelial cells were transfected with SPINK5 full
length expression vector as outlined above. Cells were
transferred to serum free media and treated with 125, 250,
or 500 mM H2O2 for 24 h. 500 mM H2O2 was chosen as the
highest physiological concentration on the basis of prelim-
inary experiments which showed that higher concentrations
have resulted in exclusive cell death. A modified 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) reduction assay was used to determine the cell
viability. Briefly, 65 mg of MTT (SigmaeAldrich Corp, St
Louis, MO) was added to each well and cells were incubated
in 5% CO2 for 4 h. Subsequent to aspiration of cell culture
medium, cells were lysed with 100 ml isopropanol and
absorbance was measured at 550 and 630 nm.
Measurement of apoptosis
Transfected A549 cells were treated with 125, 250, or
500 mM H2O2 for 24 h as outlined above. After 24 h, cell
pellets were obtained by trypsinization and washed with ice
cold PBS twice. Cells were resuspended in ice cold 1
binding buffer at a concentration of 1  106 cells/ml. 200 ml
of cell suspension were stained with annexin FITC antibody
and PI dye using ApopNexin Apoptosis Kit (Chemicon, MA,
USA) according to manufacturer’s instructions and read by
flow cytometry (Facs Aria, BD Biosciences, San Jose, CA,
USA). Annexin positive cells were considered as early while
annexin and PI double positive cells were considered as late
apoptotic. Cells that stained positively with PI only were
regarded as necrotic.
Measurement of MUC5AC expression
Transfected A549 cells were stimulated with neutrophil
elastase for 24 h. Total RNAwas isolated using RNeasymini kit
(Qiagen, Valancia, CA) according to the manufacturer’s
instructions. One microgram of total RNA was reverse tran-
scribed using ImProm-II Reverse Transcription System (Prom-
ega, Madison,WI, USA). MUC5AC genewas amplified using the
followingprimers: sense50TATGGGACTTCTCCTACCAAT30 and
antisense 50 AGCGTGGTGGACGGACAGT 30. Cyclophilin was
used as an intrinsic control. Sequence of cyclophilin primers
were as follows: sense 5-AGGTCCCAAAGACAGCAGAA-30 and
antisense, reverse 50-TGTCCACAGTCAGCAATGGT-30. Inten-
sity of amplification bands was measured by image analyzer
(Syngene Gene Genius, Cambridge, UK) by using Gene Tools
Analysis Software3.02.00 (Synoptecs software). Expression of
MUC5AC gene in unstimulated samples was arbitrarily defined
as 1 and expression index of other conditions calculated
relative to unstimulated cells.
Quantification of mucus secretion by PAS staining
A549 cells were transfected with SPINK5 expression vector
and 24 h after transfection, cells were treated with 200 nM
of neutrophil elastase (NE) and incubated for another 24 h.Mucus secretion was determined by Periodic acid-Schiff
(PAS) Staining (SigmaeAldrich Corp, St Louis, MO) by
following manufacturer instructions. Hematoxylin solution
was used for counterstaining of slides. Slides were rinsed in
running tap water, and mounted with xylene-based
mounting medium. Mucin positive cells are stained in red
with PAS staining.
Statistical analyses
Statistical analyses were done with Prism 5 for Windows
(GraphPad Software, Inc. CA, USA). Repeated measures of
ANOVA was used to compare cytokine levels, cell viability
and apoptosis in cell culture experiments. For all analyses
a p value < 0.05 was considered significant.
Results
Efficiency of transfection
PCR studies using mock transfection as negative control and
SPINK5 vector itself as positive control have shown that
transfection successfully induces expression of SPINK5 in
A549 cells (Fig. 1).
The effect of the SPINK5 on cytokine release by
A549 cell
Epithelial cells transfected with SPINK5 expression vector
produced more IL-6, IL-8 and RANTES compared to non-
transfected cells (p < 0.001, p Z 0.003, p < 0.001,
respectively, Fig. 2AeC). The background levels of RANTES
in unstimulated cells varied between 10 and 40 pg/ml as
reported before.20 There was no difference among the two
groups in IFN-g and IL-1b levels. Levels of IL-12, IL-4 and IL-
13 were mostly undetectable. Stimulation of the cells with
Der p1 failed to induce any further increase in the cytokine
and chemokine levels over that produced by unstimulated
cells or SPINK5 overexpression (data not shown).
The effect of the SPINK5 on cell viability and
apoptosis
A549 cells were stimulated with increasing doses of
hydrogen peroxide and cell viability was measured by MTT
assay and apoptosis by Annexin V/PI staining. A549 cells
transfected with the SPINK5 expression vector showed
decreased cell viability compared to non-transfected cells
Figure 2 AeC. IL-6, IL-8 and RANTES levels released from A549 cells transfected with SPINK5 vector (US Z unstimulated cells,
EV Z empty vector, SPINK5 Z SPINK5 expression vector). Columns and error bars represent mean þ SEM, N Z 3.
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the same affect on apoptosis of A549 cells as shown by
Annexin V/PI staining (Fig. 3B).
The effect of the SPINK5 on mucus production by
epithelial cells
Mucus production by A549 cells stimulated with a serine
protease, neutrophil elastase, was measured by reverse
transcriptase PCR of MUC5AC gene at mRNA level and by
PAS staining of mucins at protein level. Although SPINK5 hadFigure 3 (A) MTT assay and (B) Annexin V/PI staining shows the
increasing doses of H2O2, respectively. (USZ unstimulated cells, EV
and error bars represent mean þ SEM, N Z 3.no effect on mucus production induced by NE at the tran-
scriptional level (Fig. 4), PAS staining showed that SPINK5
slightly decreased the neutrophil elastase induced mucin
production by A549 cells compared to non-transfected cells
(Fig. 5).
Discussion
Our study shows that SPINK5 has biological actions other
than protease inhibition that may be relevant in the path-
ogenesis of asthma. These include increased production ofviability and apoptosis of A549 cells following stimulation with
Z empty vector, SPINK5Z SPINK5 expression vector). Columns
Figure 4 Effects of SPINK5 on MUC5AC expression by A549
cells stimulated with neutrophil elastase (NE). (A) Unstimu-
lated cells, (B) Cells transfected with SPINK5 expression vector
(unstimulated), (C) Cells stimulated with NE (200 mM) (no
transfection), (D) Cells transfected with SPINK5 expression
vector and stimulated with NE (200 mM). (Representative of
three independent experiments).
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viability of airway epithelial cells following an oxidant
stimulus and slightly decreased mucus production in airway
epithelial cells.Figure 5 Effects of SPINK5 on mucin production by A549 cells sti
(A) Unstimulated cells, (B) Cells transfected with SPINK5 expression
transfection), (D) Cells transfected with SPINK5 expression vecto
independent experiments).IL-6, IL-8 and RANTES are all produced at higher levels by
the resident and inflammatory cells of the asthmatic air-
ways21e23 and they have important roles in the inflamma-
tion underlying the pathogenesis of asthma. IL-6 is an
important growth factor for T and B cells and induces
antibody production21; IL-8 is a very potent chemotactic
factor for neutrophils24 and RANTES is a powerful chemo-
attractant for eosinophils.23 Judging from the effects of IL-
6, IL-8 and RANTES, there is reason to believe that SPINK5 is
capable of stimulating the involvement of a variety of
different cells such as B and T lymphocytes, neutrophils and
eosinophils that are active in the inflammatory process of
the airways through its stimulatory affects on pro-
inflammatory cytokines and chemokines.
Our findings seem to be somewhat different from
previous observations. Several studies have shown that
activation of protease-activated receptors on airway
epithelium by proteases causes the releases of IL-6 and IL-
8.7,11 In our experiments, however, Der p1, an antigen with
known protease activity, failed to induce the release of
cytokines from transfected and untransfected A549 cells.
However, the possibility to observe an effect with higher
Der p1 doses cannot be excluded.
Protease inhibitors, such as E-64, a1-AP (a1-
antiprotease), SBTI (soybean trypsin inhibitor), AEBSF, FK-
706, SLPI (secretory leukocyte protease inhibitor) were
shown to inhibit protease-activated cytokine release from
airway epithelium and other cells such as lung fibroblastsmulated with neutrophil elastase (NE) showing by PAS staining.
vector (unstimulated) (C) Cells stimulated with NE (200 mM) (no
r and stimulated with NE (200 mM). (Representative of three
354 E. Birben et al.and conjunctival epithelial cells.25 Our results show that
biological action of SPINK5 differs from other protease
inhibitors in this regard as it stimulates the release of IL-6
and IL-8. This observation strongly suggests that even
though protease inhibitors may have some common class-
defined actions and inhibit proteases, some biological
properties may be significantly different among specific
molecules.
Mucus production by airway epithelial cells protects the
respiratory tract against pathogenic and environmental
challenges such as pollens, dusts, particles and chemicals.
Secreted mucin traps particles, toxins, bacteria and viruses
in inhaled air. Mucin is generally cleared by ciliary motion
and by cough. Overproduction or decreased clearance of
mucin causes occlusion of airways with mucus plugs and is
one of the most important factors in the morbidity and
mortality of chronic airway diseases including asthma.26
Our results suggest that SPINK5 may slightly decrease
mucus production but this is not mediated by its effect on
MUC5AC expression. PAS staining is not specific for MUC5AC
protein but it stains all mucin products in the cells.
Therefore, it is possible that SPINK5 exerts its effect on
secretory mucin genes other than MUC5AC such as MUC5B,
MUC2, MUC8 and MUC19.
We have not observed any clear effect of SPINK5 on
apoptosis even though cells transfected with SPINK5 vector
displayed significantly higher cell death. Proteases such as
granzymes were shown to stimulate apoptosis by activating
several caspases such as caspase 3 and 9. Accordingly
protease inhibitors were shown to have inhibitory actions
on apoptosis.27,28 However, another protease inhibitor,
tissue factor pathway inhibitor-2 (TFPI-2), a member of the
Kunitz-type family of serine protease inhibitors, strongly
inhibits the proliferation of VSMCs without any effects on
apoptosis.29 In addition, Medicago scutellata trypsin inhib-
itor (MsTI), a serine protease inhibitor, decreased the clo-
nogenic survival of breast and cervical cancer cells.30
Therefore, proteases and protease inhibitors may have
a variety of effects on cell proliferation, cell death and
apoptosis and these effects may in fact be class specific.
Another possible reason for the lack of any effect on
apoptosis by SPINK5 may be that apoptosis induced by H2O2
may not be caspase dependent. It seems that unlike several
protease inhibitors SPINK5 does not have any effect on
apoptosis but similar to some others it decreases cell
viability. However, it must be pointed out that our results
with H2O2 cannot be directly extrapolated to other stimuli
including air pollutants, viruses such as RSV and bacteria
such as Leigonella pneomonia, diphtheria toxin and CO
even though their effect may be similar to that caused by
H2O2.The exact mechanism as well as the reason for
different effects of various proteases and protease inhibi-
tors remains to be determined.
Our study has apparent weaknesses. First of all, even
though our study defines new properties of SPINK5 other
than protease inhibition, it does not provide information
concerning its biological activity in-vivo. Secondly, even
though our result suggests that SPINK5 has certain affects
on cell viability and mucus production it does not provide
definitive information on the exact mechanisms. Finally,
other important and relevant questions such as the effect
of SPINK5 on the epithelial integrity provided by ZO1 andother tight junction molecules remain to be investigated.
These questions require further studies.
To conclude, our study suggests that SPINK5 is an
important molecule in asthma. Its role extends beyond its
well known protease inhibitor properties.
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